Alexandria, Virginia, 22301, United States
NCT Number: NCT01540929
Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel
This is a retrospective study of the Department of Defense (DoD) Smallpox Screening Form 600s (SF600s) generated during screening of service members for possible immunization with the ACAM2000® smallpox vaccine.
Primary Objective:
* To evaluate the accuracy of the DoD smallpox vaccination screening process in military personnel.
Secondary Objective:
* To describe the number of subjects who are excluded from vaccination, stratified by the pre-defined categories for exclusion (separately for the Screened and Evaluable Populations).
Looking for future studies?
Notify MeKey information
Age range
17 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
Please note that we elected to post this study on the registry (clinicaltrials.gov) in the interests of transparency and because the study represented a post-licensure commitment to FDA for ACAM2000® smallpox vaccine. However, this study was not a clinical trial and did not involve the administration of any vaccine product nor the collection of any product performance or adverse event data. Rather, the purpose of the study was to determine the success rate for proper completion and use of Department of Defense (DoD) Screening Form 600s (SF600s). The SF600 is a form required to be completed prior to smallpox vaccination of DoD staff and is used to guide decision-making by DoD vaccination staff regarding offering, postponing, or denying vaccination. The study evaluated both the extent to which the SF600s were completed correctly and the extent to which they were correctly used to guide vaccination decision-making.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Military personnel ≥17 years of age.
- Completion of the DoD Smallpox Screening Form 600 (2-part format).
Exclusion criteria
- None
Treatment and study plan
Primary outcomes
-
The percent of SF600 forms that did not clearly support the subsequent decision to vaccinate.
Time frame: 1 year post-screening
ACAM2000® Screening Accuracy Review Committee (SARC) consensus that SF600 form did not support the decision to vaccinate divided by all subjects in the Evaluable Population.
Sponsors and collaborators
Lead sponsor
Emergent BioSolutions
Industry
Registry information
Official study title
A Phase IV Post-licensure DOD Screening Accuracy Study in Military Personnel
Important dates
- Study start
- 2009
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Feb 29, 2012
- Registry last updated
- Mar 18, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
MVA Post-Event: Administration Timing and Boost Study
NCT00437021
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsA Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age
NCT05995275
Animal Diseases, DNA Virus Infections
Bradford, United Kingdom
View Trial DetailsHigh Dose IMVAMUNE® in Vaccinia-Naive Individuals
NCT00879762
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsStudy Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
NCT05935917
DNA Virus Infections, Infections
Overland Park, Kansas, United States
View Trial Details